CORONARY INTERVENT IONS
暂无分享,去创建一个
[1] M. Joner,et al. Polymer coatings on drug-eluting stents: Samson's hair and Achilles' heel? , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[2] C. Batich,et al. Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[3] R. Virmani,et al. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[4] K. Dawkins,et al. Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] M. Joner,et al. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation , 2012, Thrombosis and Haemostasis.
[6] B. Tesfamariam,et al. Induction of Nicotinamide–Adenine Dinucleotide Phosphate Oxidase and Apoptosis by Biodegradable Polymers in Macrophages: Implications for Stents , 2011, Journal of cardiovascular pharmacology.
[7] Masataka Nakano,et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.
[8] M. Joner,et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis , 2011, Thrombosis and Haemostasis.
[9] A. Kastrati,et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. , 2009, European heart journal.
[10] M. Joner,et al. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. , 2009, Minerva cardioangiologica.
[11] Peter Jüni,et al. Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis , 2009, Circulation.
[12] R. Virmani,et al. Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries , 2009, Circulation.
[13] A. Kastrati,et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. , 2009, JACC. Cardiovascular interventions.
[14] F. Eberli,et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial , 2008, The Lancet.
[15] R. Virmani,et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. , 2008, Journal of the American College of Cardiology.
[16] K. Robinson,et al. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating. , 2008, JACC. Cardiovascular interventions.
[17] Michael Joner,et al. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[18] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[19] R. Virmani,et al. Experimental efficacy of an everolimus eluting cobalt chromium stent , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] Matthew H Samore,et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. , 2006, Journal of the American College of Cardiology.
[21] R. Virmani,et al. Stent‐based delivery of ABT‐578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[22] J. Loo,et al. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. , 2005, Biomaterials.
[23] P. Tsao,et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. , 2004, Cardiovascular research.
[24] Giuseppe Musumeci,et al. Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.
[25] R. Virmani,et al. Drug eluting stents: are human and animal studies comparable? , 2003, Heart.
[26] Renu Virmani,et al. Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.
[27] P. Tsao,et al. Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model , 2001, Circulation.
[28] K. Pethig,et al. Silicon Carbide-Coated Stents: Clinical Experience in Coronary Lesions with Increased Thrombotic Risk , 1998, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.
[29] R E Vlietstra,et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.
[30] R. Virmani,et al. Neointimal responses 3 months after (32)P beta-emitting stent placement. , 2000, International journal of radiation oncology, biology, physics.